Brief: Amicus Therapeutics Announces Full-Year 2022 Financial Results And Corporate Updates
Amicus Therapeutics Inc FOLD.O :
* AMICUS THERAPEUTICS ANNOUNCES FULL-YEAR 2022 FINANCIAL
RESULTS
AND CORPORATE UPDATES
* AMICUS THERAPEUTICS INC- IS ON-TRACK TO ACHIEVE NON-GAAP
PROFITABILITY IN SECOND HALF OF 2023
* AMICUS THERAPEUTICS INC- U.S. FDA PRE-APPROVAL INSPECTION
FOR
AT-GAA NOW SCHEDULED; APPROVAL EXPECTED IN 3Q 2023
* AMICUS THERAPEUTICS INC- EU AND U.K. AT-GAA REGULATORY
REVIEWS
ON-TRACK; APPROVALS EXPECTED IN 3Q 2023
Source text for Eikon: ID:nGNX8kqlVX
Further company coverage: FOLD.O
Recent news on Amicus Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates